|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for CACNA1A |
Basic gene info. | Gene symbol | CACNA1A |
Gene name | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | |
Synonyms | APCA|BI|CACNL1A4|CAV2.1|EA2|FHM|HPCA|MHP|MHP1|SCA6 | |
Cytomap | UCSC genome browser: 19p13 | |
Genomic location | chr19 :13317255-13617274 | |
Type of gene | protein-coding | |
RefGenes | NM_000068.3, NM_001127221.1,NM_001127222.1,NM_001174080.1,NM_023035.2, | |
Ensembl id | ENSG00000141837 | |
Description | brain calcium channel 1brain calcium channel Icalcium channel, L type, alpha-1 polypeptidevoltage-dependent P/Q-type calcium channel subunit alpha-1Avoltage-gated calcium channel subunit alpha Cav2.1 | |
Modification date | 20141222 | |
dbXrefs | MIM : 601011 | |
HGNC : HGNC | ||
Ensembl : ENSG00000141837 | ||
HPRD : 03004 | ||
Vega : OTTHUMG00000044590 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CACNA1A | |
BioGPS: 773 | ||
Gene Expression Atlas: ENSG00000141837 | ||
The Human Protein Atlas: ENSG00000141837 | ||
Pathway | NCI Pathway Interaction Database: CACNA1A | |
KEGG: CACNA1A | ||
REACTOME: CACNA1A | ||
ConsensusPathDB | ||
Pathway Commons: CACNA1A | ||
Metabolism | MetaCyc: CACNA1A | |
HUMANCyc: CACNA1A | ||
Regulation | Ensembl's Regulation: ENSG00000141837 | |
miRBase: chr19 :13,317,255-13,617,274 | ||
TargetScan: NM_000068 | ||
cisRED: ENSG00000141837 | ||
Context | iHOP: CACNA1A | |
cancer metabolism search in PubMed: CACNA1A | ||
UCL Cancer Institute: CACNA1A | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for CACNA1A(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: CACNA1A |
Familial Cancer Database: CACNA1A |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM |
Mutations for CACNA1A |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
breast | CACNA1A | chr19 | 13465183 | 13465183 | CACNA1A | chr19 | 13571983 | 13571983 |
ovary | CACNA1A | chr19 | 13420179 | 13420199 | AP1M1 | chr19 | 16326836 | 16326856 |
ovary | CACNA1A | chr19 | 13578691 | 13578711 | CACNA1A | chr19 | 13579253 | 13579273 |
pancreas | CACNA1A | chr19 | 13319274 | 13319294 | CACNA1A | chr19 | 13379210 | 13379230 |
pancreas | CACNA1A | chr19 | 13331829 | 13332029 | chr5 | 71031888 | 71032088 | |
pancreas | CACNA1A | chr19 | 13341109 | 13341129 | chr19 | 32343173 | 32343193 | |
pancreas | CACNA1A | chr19 | 13377068 | 13377088 | chr19 | 27812091 | 27812111 | |
pancreas | CACNA1A | chr19 | 13408055 | 13408075 | CACNA1A | chr19 | 13438303 | 13438323 |
pancreas | CACNA1A | chr19 | 13412311 | 13412511 | LOC100506012 | chr19 | 47020546 | 47020746 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows CACNA1A related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
AA772930 | CACNA1A | 2 | 77 | 19 | 13318845 | 13319628 | DNAJC13 | 78 | 423 | 3 | 132235269 | 132241832 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 4 |   | 1 | 4 |   |   | 1 |   | 1 |   | 9 |   |   |   | 1 |   |   | |||
GAIN (# sample) | 4 |   | 1 | 4 |   |   | 1 |   | 1 |   | 9 |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 1 |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=148) | (# total SNVs=61) |
(# total SNVs=12) | (# total SNVs=3) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr19:13418659-13418659 | p.F641F | 6 |
chr19:13319693-13319693 | p.H2219H | 4 |
chr19:13365981-13365981 | p.F1561F | 3 |
chr19:13566007-13566007 | p.L105V | 3 |
chr19:13470495-13470495 | p.F301F | 3 |
chr19:13428038-13428038 | p.R481R | 2 |
chr19:13397337-13397338 | p.L1178fs*38 | 2 |
chr19:13409696-13409696 | p.E917D | 2 |
chr19:13418632-13418632 | p.F650F | 2 |
chr19:13423526-13423526 | p.T542M | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 7 | 16 |   | 27 | 3 |   | 12 | 2 | 4 | 2 | 1 | 26 | 10 | 4 |   | 2 | 50 | 18 | 2 | 19 |
# mutation | 8 | 17 |   | 40 | 3 |   | 13 | 2 | 5 | 2 | 1 | 28 | 11 | 4 |   | 2 | 62 | 24 | 2 | 29 |
nonsynonymous SNV | 5 | 13 |   | 28 | 1 |   | 7 | 2 | 3 | 2 |   | 18 | 9 | 3 |   | 2 | 27 | 16 | 2 | 19 |
synonymous SNV | 3 | 4 |   | 13 | 2 |   | 6 |   | 2 |   | 1 | 10 | 2 | 1 |   |   | 35 | 8 |   | 10 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr19:13418659 | p.F642F,CACNA1A | 6 |
chr19:13365981 | p.F1562F,CACNA1A | 4 |
chr19:13365963 | p.G677E,CACNA1A | 2 |
chr19:13339571 | p.R1349W,CACNA1A | 2 |
chr19:13414691 | p.E672K,CACNA1A | 2 |
chr19:13387897 | p.L1623L,CACNA1A | 2 |
chr19:13418631 | p.N671N,CACNA1A | 2 |
chr19:13418632 | p.R1880W,CACNA1A | 2 |
chr19:13397745 | p.G667G,CACNA1A | 2 |
chr19:13325357 | p.F301F,CACNA1A | 2 |
Other DBs for Point Mutations |
Copy Number for CACNA1A in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for CACNA1A |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AP1M1,MRGPRG-AS1,COLCA2,C15orf41,C1QL3,BPIFB3,C4BPA, CACNA1A,CYP7A1,DCAF15,DDX39A,GPR85,MROH2B,KCNB2, KCNS1,MEIS2,MRGPRG,MUC7,PRTFDC1,SLC25A37,ZSWIM4 | C14orf119,C1orf110,C8orf59,CACNA1A,COMMD6,DACT3,DAD1, DSTN,FAM127B,FAM127C,FKBP1B,FLJ42393,KRTCAP2,LOC285954, LSM2,MAX,PRAF2,RAC1,SUPT4H1,TMEM60,UBE2Q1 | ||||
ABCC12,ACTL6B,APLP1,ATP2B2,BTBD17,LINC00588,CACNA1A, CACNG3,CHST8,CUX2,FEV,HCN4,INSRR,JPH4, LIN28A,NEUROD2,SEZ6,SSTR2,SYT6,THSD7B,VWA5B2 | CACNA1A,CALN1,CELSR1,COL2A1,DSCAML1,AMER3,FEV, GPR119,HOXD12,INSM1,MARCH4,NKX2-2,PAX3,PYY, RFX6,RIMBP2,SLC18A1,ST6GAL2,TBX4,TOX2,VWA5B2 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for CACNA1A |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00230 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | illicit; approved; investigational | Pregabalin | ||
DB00661 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | approved | Verapamil | ||
DB00836 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | approved | Loperamide | ||
DB01244 | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | approved | Bepridil |
Top |
Cross referenced IDs for CACNA1A |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |